![Christos KONTOS | Assistant Professor | PhD | National and Kapodistrian University of Athens, Athens | uoa | Department of Biochemistry and Molecular Biology | Research profile Christos KONTOS | Assistant Professor | PhD | National and Kapodistrian University of Athens, Athens | uoa | Department of Biochemistry and Molecular Biology | Research profile](https://i1.rgstatic.net/ii/profile.image/928768319307785-1598447031625_Q512/Christos-Kontos.jpg)
Christos KONTOS | Assistant Professor | PhD | National and Kapodistrian University of Athens, Athens | uoa | Department of Biochemistry and Molecular Biology | Research profile
Maria Alexandra Papadimitriou on LinkedIn: Epi‐miRNAs: Modern mediators of methylation status in human cancers
![Maria PAPATSIROU | PhD Student | Bachelor of Science | National and Kapodistrian University of Athens, Athens | uoa | Department of Biochemistry and Molecular Biology | Research profile Maria PAPATSIROU | PhD Student | Bachelor of Science | National and Kapodistrian University of Athens, Athens | uoa | Department of Biochemistry and Molecular Biology | Research profile](https://i1.rgstatic.net/ii/profile.image/11431281178785478-1691059041759_Q512/Maria-Papatsirou.jpg)
Maria PAPATSIROU | PhD Student | Bachelor of Science | National and Kapodistrian University of Athens, Athens | uoa | Department of Biochemistry and Molecular Biology | Research profile
Maria Alexandra Papadimitriou on LinkedIn: Epi‐miRNAs: Modern mediators of methylation status in human cancers
![Life | Free Full-Text | Robust Neutralizing Antibody Responses 6 Months Post Vaccination with BNT162b2: A Prospective Study in 308 Healthy Individuals Life | Free Full-Text | Robust Neutralizing Antibody Responses 6 Months Post Vaccination with BNT162b2: A Prospective Study in 308 Healthy Individuals](https://www.mdpi.com/life/life-11-01077/article_deploy/html/images/life-11-01077-g001.png)
Life | Free Full-Text | Robust Neutralizing Antibody Responses 6 Months Post Vaccination with BNT162b2: A Prospective Study in 308 Healthy Individuals
![Stavroula PASCHOU | Assistant Professor of Endocrinology | Assistant Professor of Endocrinology | Department of Clinical Therapeutics, Alexandra Hospital | Research profile Stavroula PASCHOU | Assistant Professor of Endocrinology | Assistant Professor of Endocrinology | Department of Clinical Therapeutics, Alexandra Hospital | Research profile](https://i1.rgstatic.net/ii/profile.image/1006021065592832-1616865521029_Q512/Stavroula-Paschou.jpg)
Stavroula PASCHOU | Assistant Professor of Endocrinology | Assistant Professor of Endocrinology | Department of Clinical Therapeutics, Alexandra Hospital | Research profile
![Efficacy and Toxicity of Selinexor: Importance of Dose Intensity and Post Progression Outcomes - YouTube Efficacy and Toxicity of Selinexor: Importance of Dose Intensity and Post Progression Outcomes - YouTube](https://i.ytimg.com/vi/1Oje9ioSVHs/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLBbmjVwlU0noicnM_8UvRJY8io7lg)
Efficacy and Toxicity of Selinexor: Importance of Dose Intensity and Post Progression Outcomes - YouTube
![IJMS | Free Full-Text | Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma IJMS | Free Full-Text | Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma](https://pub.mdpi-res.com/ijms/ijms-24-11829/article_deploy/html/images/ijms-24-11829-g001.png?1690106012)
IJMS | Free Full-Text | Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma
![Viruses | Free Full-Text | Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials Viruses | Free Full-Text | Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials](https://www.mdpi.com/viruses/viruses-15-00765/article_deploy/html/images/viruses-15-00765-g001.png)
Viruses | Free Full-Text | Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials
![Cancers | Free Full-Text | Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study Cancers | Free Full-Text | Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study](https://www.mdpi.com/cancers/cancers-13-01257/article_deploy/html/images/cancers-13-01257-g001.png)
Cancers | Free Full-Text | Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study
![Michalis LIONTOS | Medical Oncologist, Locum Consultant | MD, PhD | National and Kapodistrian University of Athens, Athens | uoa | Division of Clinical Therapeutics, Oncology Department | Research profile Michalis LIONTOS | Medical Oncologist, Locum Consultant | MD, PhD | National and Kapodistrian University of Athens, Athens | uoa | Division of Clinical Therapeutics, Oncology Department | Research profile](https://i1.rgstatic.net/ii/profile.image/278598951948300-1443434574557_Q512/Michalis-Liontos.jpg)
Michalis LIONTOS | Medical Oncologist, Locum Consultant | MD, PhD | National and Kapodistrian University of Athens, Athens | uoa | Division of Clinical Therapeutics, Oncology Department | Research profile
![Medical Sciences | Free Full-Text | Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature Medical Sciences | Free Full-Text | Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature](https://www.mdpi.com/medsci/medsci-11-00035/article_deploy/html/images/medsci-11-00035-g001-550.jpg)